Gene · 4607
Papers3,985
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,985
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy. | Eur Heart J | 2023 | 37804245 | PubTator, text mining | PubMed |
| ERRγ agonist under mechanical stretching manifests hypertrophic cardiomyopathy phenotypes of engineered cardiac tissue through maturation. | Stem Cell Reports | 2023 | 37802074 | PubTator, text mining | PubMed |
| Functional mutation, splice, distribution, and divergence analysis of impactful genes associated with heart failure and other cardiovascular diseases. | Sci Rep | 2023 | 37798313 | PubTator, text mining | PubMed |
| Nonsense mediated decay factor UPF3B is associated with cMyBP-C haploinsufficiency in hypertrophic cardiomyopathy patients. | J Mol Cell Cardiol | 2023 | 37797718 | PubTator, text mining | PubMed |
| Diagnostic yield of genetic testing in a multinational heterogeneous cohort of 2088 DCM patients. | Front Cardiovasc Med | 2023 | 37795486 | PubTator, text mining | PubMed |
| An Unbiased Screen Identified the Hsp70-BAG3 Complex as a Regulator of Myosin-Binding Protein C3. | JACC Basic Transl Sci | 2023 | 37791314 | PubTator, text mining | PubMed |
| Going Further With Half as Much: It's in the BAG. | JACC Basic Transl Sci | 2023 | 37791297 | PubTator, text mining | PubMed |
| Human skeletal myopathy myosin mutations disrupt myosin head sequestration. | JCI Insight | 2023 | 37788100 | PubTator, text mining | PubMed |
| Sarcomeric gene variants among Indians with hypertrophic cardiomyopathy: A scoping review. | Indian J Med Res | 2023 | 37787257 | PubTator, text mining | PubMed |
| Case report: A rare case of left ventricular noncompaction in two Chinese siblings with becker muscular dystrophy caused by deletion of exons 10 to 12 in the DMD gene. | Front Cardiovasc Med | 2023 | 37781315 | PubTator, text mining | PubMed |
| An Unusual Presentation of Apical Hypertrophic Cardiomyopathy in an Orthotopic Heart Transplant Recipient. | Cureus | 2023 | 37779770 | PubTator, text mining | PubMed |
| Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment. | Front Bioeng Biotechnol | 2023 | 37771571 | PubTator, text mining | PubMed |
| Genetic Contribution to End-Stage Cardiomyopathy Requiring Heart Transplantation. | Circ Genom Precis Med | 2023 | 37767697 | PubTator, text mining | PubMed |
| Editorial: Case reports in cardiovascular genetics and systems medicine: 2022. | Front Cardiovasc Med | 2023 | 37767370 | PubTator, text mining | PubMed |
| Alcohol septal ablation for hypertrophic obstructive cardiomyopathy and bilateral lung transplantation for idiopathic pulmonary fibrosis: a case report. | Eur Heart J Case Rep | 2023 | 37767234 | PubTator, text mining | PubMed |
| Flagellin-Induced Immune Response in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. | Int J Mol Sci | 2023 | 37762236 | PubTator, text mining | PubMed |
| The Relationship between Changes in MYBPC3 Single-Nucleotide Polymorphism-Associated Metabolites and Elite Athletes' Adaptive Cardiac Function. | J Cardiovasc Dev Dis | 2023 | 37754829 | PubTator, text mining | PubMed |
| Long-Term Prognosis of Different Subtypes of Left Ventricular Noncompaction Cardiomyopathy Patients: A Retrospective Study in China. | J Cardiovasc Dev Dis | 2023 | 37754798 | PubTator, text mining | PubMed |
| Novel MYBPC3 Mutations in Indian Population with Cardiomyopathies. | Pharmgenomics Pers Med | 2023 | 37750083 | PubTator, text mining | PubMed |
| The Genetic Evaluation of Dilated Cardiomyopathy. | Struct Heart | 2023 | 37745678 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/papers?page=20